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Abstract
Background: Older people with advanced kidney disease require information and support from clinicians when
deciding whether to have dialysis or conservative (non-dialysis) care. There is evidence that communication practices,
information provision and treatment rates vary widely across renal units. However, experiences of communicating with
clinicians among patients receiving conservative care are poorly understood. This evidence is essential to ensure
support is patient-centred and equitable. Our aim was to explore views and experiences of communication,
information provision and treatment decision-making among older patients receiving conservative care.
Methods: In-depth qualitative interviews were conducted with patients with stage 5 chronic kidney disease from three
UK renal units. Purposive sampling captured variation in age, co-morbidity and functional status. Interviews were analysed
thematically.
Results: 20 patients were interviewed (11 were men; median age 82 (range 69–95)). Participants described positive
experiences of communicating with clinicians and receiving information, but also negative experiences involving
insensitivity, rushing or ambiguity. Participants reported clinicians omitting/avoiding conversations regarding diagnosis
and prognosis, and described what helped and hindered good communication and support. They wanted information
about their treatment options and illness, but expressed ambivalence about knowing details of disease progression.
Clinicians’ views and recommendations regarding treatment influenced patients’ decision-making.
Conclusions: Older patients report variable quality in communication with clinicians and gaps in the information
received. Uncertainty about the disease trajectory and patients’ ambivalence regarding information makes
communication particularly challenging for clinicians. Tailoring information to patient preferences and conveying it
clearly and sensitively is critical. Renal clinicians require support and training to ensure decision-making support for
older patients is patient-centred. Future research should examine how clinicians’ communication practices influence
treatment decision-making.
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Background
Each year, more than 3500 UK residents and 55,000 US res-
idents over 65 develop end stage kidney disease (ESKD)
and start dialysis [1, 2]. Most travel to a dialysis unit three
times each week until they die. While initiating dialysis
lengthens life for some older adults, the survival benefit ap-
pears small or non-existent in those with comorbidities or
frailty [3]. The burden of dialysis and its effect on quality of
life also outweigh the benefit of longevity for some patients
[4, 5]; hence chosen or medically advised ‘comprehensive
conservative kidney care’ [6] is recognised as an acceptable
alternative [4, 7]. It comprises all aspects of renal care with-
out preparing for dialysis, in conjunction with a multidis-
ciplinary palliative care approach [6]. Patients receiving
conservative care spend less time having treatment and are
less likely to be admitted to or die in hospital [8–10].
A major challenge for renal clinicians is supporting
and informing people with advanced kidney disease as
they negotiate treatment options and decide on future
treatment. Clinicians report difficulties conveying the
uncertainty surrounding treatment options and judging
how much information to share [11]. There is evidence
that clinicians’ communication practices are inconsistent:
patients from renal units with a more established con-
servative care pathway are more aware of conservative
management, less often believe that dialysis guarantees
longevity, and have more often discussed the future with
staff [12]. In addition, the format, quality and accessibil-
ity of information resources [13] and decision aids [14]
vary across renal services, as do patient ratings of the
quality of communication and decision-making support
[15]. These inconsistencies are associated with unwar-
ranted geographical variation in treatment rates for older
adults with ESKD [16–18].
Understanding patients’ experiences of communicating
with and receiving information from renal clinicians is
crucial to inform clinical practice and staff education,
and to ensure equity in the management of ESKD. How-
ever, previous qualitative research has predominantly fo-
cused on patients’ reasons for opting for conservative
care [19–21]. We therefore aimed to explore views and
experiences of communication and information
provision among patients with ESKD receiving conserva-
tive care, and their views of the treatment decision.
Methods
Study design
Cross-sectional, in-depth qualitative interviews with pa-
tients who were recruited as part of a larger longitudinal
study [22].
Setting
Three renal units at hospitals in London and South-East
England: Guy’s Hospital, King’s College Hospital, and
East Kent Hospitals. All three renal units had specific
conservative (non-dialysis) management services at the
time of the study. The London units had dedicated renal
palliative care nurse specialists coordinating and provid-
ing much of the service, including clinic review and
home visits as necessary, with support from nephrology
staff as required. The third unit is more rural, and of-
fered more home-based care (including home visits from
nephrology staff ), telephone support, and integration
with primary care and specialist palliative care.
Sampling
Participants had made a definite decision, in discussion
with their nephrology teams, for conservative manage-
ment and were being conservatively managed at the time
of the interview. Inclusion criteria were chronic kidney
disease (CKD) stage 5 [23], definite decision for conserva-
tive management, and estimated glomerular filtration rate
(eGFR) ≤ 15mL/minute [24] at recruitment into the longi-
tudinal study [22]; qualitative interviews were conducted
within three months. Patients who lacked capacity to
consent were excluded. Purposive sampling captured vari-
ation in age, co-morbidity and functional status. Sampling
continued until data saturation, i.e. no new themes were
identified in later interviews [25].
Recruitment
Clinicians gave patients information about the study. FM
contacted and recruited interested patients by telephone.
Participants gave written informed consent.
Data collection
An interview topic guide (Table 1) was developed based
on study objectives and piloted with three patients (data
not included). All interviews were conducted in 2007 by
FM, a palliative care clinician trained in in-depth inter-
viewing who was conducting a PhD in Palliative Care.
She was not known to the participants, was not involved
in their care, and was introduced as an independent re-
searcher. Interviews were audio-recorded, transcribed
verbatim and anonymised. Names were changed to age-
and ethnicity-specific alternatives. Field notes made dur-
ing the interview were integrated in the analysis.
Interviews were conducted according to participants’
preferences, usually (17/20) in their own home. One
interview was in a nursing home, and two interviews at
a relative’s house, where the participant lived. Where
possible, participants were interviewed alone; 7/20 inter-
views were conducted with a spouse/family member
present, either because participants asked for them to be
present (3/20), or because there was no alternative living
space for family members.
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Analysis
Interviews were analysed using inductive thematic ana-
lysis [26], a theoretically flexible approach appropriate
in exploratory research [27]. Our research was in the
subtle realist paradigm, in which reality is conceptua-
lised as existing objectively, but known only from each
individual’s own perspective [28]. Data were managed
in NVivo [29], and analysed following these steps: (1)
Familiarisation, via detailed reading of transcripts and
field notes, and making reflective comments on the na-
ture and content of the interviews (FM). (2) Develop-
ment of a formal coding index to capture themes and
sub-themes in the data. This was an iterative process
which involved double coding of three transcripts, add-
itional in-depth coding to meet the aims of the analysis
reported here (LES), and discussion across the research
team (FM/LES/KB). We used a combination of induct-
ive coding based on close reading of the data and de-
ductive coding based on the study aims. (3) Application
of the finalised coding frame to all transcripts (FM/
LES). (4) Narrative synthesis of themes, paying atten-
tion to patterns in the data and deviant cases (LES).
The synthesis was critically reviewed within the re-
search team and refined.
Ethics
Ethical approval for all research sites was obtained from
King’s College Hospital Research Ethics Committee
(COREC number 04–03-092, 2006). All participants gave
written informed consent.
Results
Participants
Twenty-one patients were invited to participate. One de-
clined due to ill health; the remaining 20 were inter-
viewed. Interviews lasted 38–74min. Participants had a
median age of 82 years (range 69–95) and 11 were men
(Table 2). Median eGFR at study entry was 12.3 mL/min
(range 6.5–14.9 mL/min), median Karnofsky Perform-
ance Status Score was 60% (range 40–80%), and median
Charlson Comorbidity Index Score was 4 (range 4–8).
Results
Findings are presented in four themes: 1. Participant
views and experiences of staff-patient communication;
2. Information provision (sub-themes: receiving
information from staff; missing conversations and
gaps in information provision); 3. Information prefer-
ences; 4. Dialysis decision-making (sub-themes: agency
and preferences; reasons for treatment decision;
feelings about the decision). Illustrative quotes use
pseudonyms.
Participant views and experiences of staff-patient
communication
Participants described positive experiences of communi-
cating with their healthcare providers, including General
Practitioners (family doctors), renal clinicians and pallia-
tive care providers. Participants appreciated it when staff
took time to communicate and answer their questions:
“I mean it’s, it’s a very, very nice feeling to be able to go
there and know… that you can ask them any question
you like. It doesn’t matter how it sounds to be but to
you it’s important and they answer you and they’ve got
time, that’s the thing, time for you…” Walter.
“Maybe, if he [the nephrologist] had asked me [pause]… I
… kind of knew, I think, but if he had asked me, maybe,
what do you think…or…what do you understand? So I
could kind of hear things more slowly. But I don’t think
he liked talking about it, he just wanted to get it done
and out and on, quickly.” Joseph.
Using comprehensible, unambiguous language was
critical:
“It’s been good if it is easy to understand, if it makes
sense, if it is in my sort of language… not lots of
Table 1 Topic guide
Interview topic Areas covered
Background Age
Social circumstances
Duration of kidney problem
Duration of attendance at nephrology
department
Current functional ability
Understanding of illness Understanding of their kidney disease
Illness impact How the kidney disease is affecting
them, including:
• Overall impact on their life
• Particular effects – both physical
and psychological
• What is changing for them
• Impact patient perceives on
family/carers
The relative importance of the different
factors described [Prompt: the role of
symptoms]
How they see the illness affecting them
in the future
Information and
decision-making
Experiences of illness information and
involvement in healthcare decisions,
including:
• Factors influencing the experiences
• Relative importance of these factors
• Anything which might cause a future
change in decision
• Prompt regarding dialysis decision if not
spontaneously introduced
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medical stuff I don’t know. [Name of renal palliative
nurse] is very good at that, anything I don’t
understand she’ll tell me, blood tests or something.”
Dorothy.
“I didn’t know I had a problem with my kidneys until I
was at the diabetic clinic when they said they would
‘keep an eye on’ my kidneys. But that didn’t really mean
much to me, keeping an eye on my kidneys, you know.
And it wasn’t until I was referred to [name of
nephrologist] and she explained things to me, that I
realised it, it was quite serious.” Florence.
Participants described the need for clinicians to bal-
ance being straight-forward, honest and matter-of-fact in
their approach with being sensitive and personal:
“I get the impression they don’t run away from it there
[at hospice], they know you’ll die and meet that head
on, like [hospice nurse], when she came she was honest
and spoke about it, but not to make it worse, just to
explain, what to expect and what to do.” Charles.
“[Palliative care] went more steady about things,
gentle… Knew how to talk about things. Not a sort
of blunt approach… ‘let’s get this done’, but more…
‘well, let’s find out what’s happening, is there
anything we can do…what would you like to know?’
… Don’t misunderstand me, they could still talk
about difficult things, what was happening, not
having the dialysis and what that meant. It was
just the way they did it. Gentle, and a kind of
personal approach.” Joseph.
This was contrasted with clinicians avoiding key issues
or being insensitive, brusque or abrupt:
“[Name of nephrologist] himself when I was still in the
hospital, he said ‘If you’re still here in a few weeks or a
few months, then I would be gobsmacked’ he said, not
a phrase we liked. ‘If it lasted a year I would be
surprised’ would be better.” Charles.
Good communication was facilitated by a context of
continuous care and an ongoing staff-patient
relationship:
“You feel more relaxed, I mean, knowing there’s always
somebody there. There’s always somebody you can turn
to, and I think that’s an ever-so-nice feeling, gives you
a feeling of, a little bit of confidence in yourself I
think.” Donald’s carer.
Conversely, poor continuity of care and lack of an on-
going relationship could prevent good communication:
“It was a bit of a problem in the beginning. (Pause). It
was…er…it was not very good…I have to be honest…in
the early days going back and forth for the tests and so
on, it wasn’t very easy. Every time seemed to be some
new doctor, usually I think it was the junior doctors,
the regist… registrars are they?” Betty.
Table 2 Participants’ clinical characteristics (n = 20)
Participants 20
Gender
Female 11
Male 9
Age
< 75 2
75–79 5
80–84 8
≥ 85 5
Marital Status
Married 8
Widowed 9
Single 3
Ethnicity
White British 18
Afro-Caribbean 1
Other 1
Renal Diagnosis
Diabetes Mellitus 5
Glomerulo-nephritis 3
Renal vascular disease 2
Unknown 9
Other 1
Karnofsky Performance Status Score [56]
40% 3
50% 3
60% 4
70% 7
80% 3
Modified Charlson Comorbidity Index Score*
2 2
3 5
4 5
5 4
6 3
8 1
*Charlson Comorbidity Index [57] modified for renal patients to exclude renal
diagnosis and age from the scoring [58]
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Negative experiences of communication could have a
significant impact; Joseph described being told, bluntly,
he couldn’t have dialysis by a consultant he had met just
once before:
“It did worry me at the time. It upset me very much. I felt
quite down, quite depressed about it. It was like being
written off, in a way… like, ‘We can’t help you, so off you
go, not our problem, just cope with it.’ It made me feel
awful.” Joseph.
Information provision
Receiving information from staff
Most patients reported good experiences of accessing in-
formation from healthcare providers, with 17/20 saying
they had good/adequate information at the time of de-
ciding about whether to have dialysis:
“They’ve been very good, all the way, just ask anything
and they tell you. There’s never been any problems like
that, or not finding out what you wanted or anything.
No, they’ve been good, very good.” Walter.
Renal nurses, supportive/palliative care nurses and
nephrology consultants were the primary source of in-
formation, with leaflets/ hospital education sessions also
mentioned. One patient had been referred to a pharma-
cist for detailed information about medicines. Outside of
healthcare, patients consulted books and talked to others
with kidney disease.
Participants stressed the importance of staff providing
information proactively:
“[The renal nurse] went all into it in, in, when I first
went over there. I was, you know, I was really
surprised, cos normally you go in to see the nurse and
oh yes, they, they do what they gotta do and that’s it,
but she did go in to everything and... she was so good,
explained it all. Made it all so clear.” Donald.
Two patients reported that their own forgetfulness
limited their ability to retain information:
Interviewer: “Can you tell me, have the, the doctors
and nurses explained much to you about your kidney
problem?”
Lilian: “Not really, I suppose. I don’t know. I suppose
they did, but I’m so forgetful now that I forget all
about it [laughing].”
Another said information “goes in one ear and out the
other” (Walter).
Missing conversations and gaps in information provision
There were two clear areas in which information was
lacking: diagnosis and disease progression. Four patients
reported delays in being told about their condition,
knowing or suspecting that doctors knew there was a
problem before they were informed:
“They should have said to me earlier about the
problem… ‘Cos they must have known about it for
some time… As soon as there’s a problem, yes, I think
you should know about it and if there anything you
can do.” Florence.
Patients’ hypothesised reasons for this were staff not
wanting to concern or worry the patient needlessly, and
avoiding/putting off the discussion, e.g. by repeating
tests rather than talking about the situation:
“I think they [junior doctors] didn’t know what to say
sometimes, and it often seemed to be a case of ‘Well,
let’s see next time.’ There is only so many times you
want to hear that. I’m not silly… I know how to put
two and two together…and I was beginning to work
things out. But it took them a long time to tell me,
really. I don’t know if it was that they didn’t really
know for a while, or they didn’t want to say, but I felt
it wasn’t good, no.” Betty.
Not being told about their condition in a timely man-
ner had negative consequences as patients couldn’t
adapt their diet and health behaviour, e.g.
Karif: “I was upset…at the beginning, yes.”
Interviewer: “Mmhm……what upset you?”
Karif: “That I was sick… I was sick without knowing…
That I was doing things I was not supposed to do.”
However, knowledge was acknowledged to have both
positive and negative consequences, which could be hard
to anticipate. Karif later said that, on reflection, knowing
about his kidney disease hadn’t changed his behaviour and
had caused worry, so he wished, despite the advantages of
knowing, that he hadn’t been told at all. One patient re-
ported that not being told earlier in the disease trajectory
had upset his wife, although he did not mind himself:
“It bothered her a lot. Not me. I think… if you need
something done then they’ll do it, won’t they? I reckon
I didn’t need anything before then. The wife thinks
different… she says if they can’t tell you, if it takes
seven years for someone to tell you what is happening,
and they say, well they can’t do nothing about it, but
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then all of a sudden they start sending you all these
letters to go to [the renal unit] to see a nephrologist …
she says they ought to have done something before.”
Michael.
The second gap in information related to what to ex-
pect as disease progressed and death approached. Renal
clinicians reportedly had difficulty dealing with the un-
certainty of the condition and answering questions about
disease progression; participants contrasted this with the
more straight-forward approach of hospice staff:
Charles: “In the background of my mind all the time is
this wish to know a little bit more about the next
phase… I do understand that they can’t say nearer than
so many weeks, so many days but it leaves you, it leaves
us both in a strange limbo which the world, the world
becomes unreal after, you just have no idea but it
becomes so much part of you that you forget to say it.”
Interviewer: “And is, is that something you’ve been
able to ask professionals about?”
Charles: “Been able to ask but they’ve always been
very skilled in not telling you. Except [name of hospice
nurse], she was honest, but none of the others. Most of
them, well there’s kind of a lot of hedging… they just
don’t know, and aren’t able to talk about not knowing
very well.”
Reported consequences of lacking information about
disease progression were that patients did not know
what symptoms or problems were attributable to their
renal disease, and worried about what would happen (in-
cluding where they would be cared for) as they became
more ill.
Information preferences
Participants’ attitudes to information varied. In general,
they wanted information about their treatment options
and renal disease:
Interviewer: “Yeah, some people prefer to have more
information and some people prefer to have less. What
about you?”
Charles: “Oh yeah, obviously more, more. The more I
understand, the better. I always have wanted to know
what’s going on, to try and understand – it helps you
to know what you can do, doesn’t it?”
However, there were exceptions and caveats. Betty said
she did not want in-depth information about dialysis
from the renal nurse as she had already decided not to
have dialysis:
“I said to [renal nurse], ‘Don’t tell me about all this
dialysis, will you, because I don’t want to hear about
it’. I’d already made up my mind, so what was the
point. But she was trying to be sure I understood what
I was turning down, so that’s fair enough.” Betty.
Joseph said that although he wanted information, how
it was conveyed was just as important as the content/
amount of information. He appreciated that some clini-
cians tailored information and asked what information
was wanted. Florence recognised the clinical challenge
of tailoring information provision:
“They have to tell you, unless of course… they know
their patients and they can say ‘Well, I don’t think it’s
a good thing to tell this patient ‘cos she could get
hysterical and throw a wobbly’… but for me I think I
would have liked to have been told. They should have
told me sooner. But then perhaps other people
wouldn’t like to be told. I don’t know what the answer
to that is, at least not for everyone.” Florence.
All except one patient spoke about their poor progno-
sis, either openly or implicitly. But several were ambiva-
lent about receiving prognostic information, or preferred
not to know details. Harold expressed the dilemma that
information about the end of life raised for him:
“It gets to a point – certain things really it’s probably
best not to know, but I don’t know. Sometimes I don’t
ask, because it makes you worry, but then you still
worry if you don’t know.” Harold.
Two participants talked about the limitations of health
professionals’ own knowledge:
Michael: “One of the things I’d like to know is how long
my kidneys will last but they can’t tell you that exactly,
and they said four or five years, so that’s not their fault
is it? I want to sit down and get real answers, but the
answers aren’t always there, are there?”
Interviewer: “That can be difficult. What do you
think?”
Michael: “Sometimes, you get the feeling that they
don’t know either… So if I ask about the kidney that’s
one thing, but then if I ask something more … difficult
[pause] … like what’s going to happen to me when…
that, they don’t know the answer to… but they don’t
always say.”
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Clinicians and patients were described as “in the hands
of a mystery” (George); for example, George wanted to
know what caused his terrible itching, Alice worried
about getting water on her lungs, and Michael felt renal
clinicians didn’t understand his other health problems or
their interaction with his renal disease (“it’s like they
know one bit of you, but not the other bits, if you know
what I mean”).
Four participants were clear that details about the
future, especially details of how death might be,
were not something they really wanted to discuss.
Mildred was very definite that she would rather not
know:
“I suppose kidney trouble is the same as any other
trouble, eventually it takes over you and you die. This
is, this is the truth of it… I went up and they said, ‘You
want to know what’s going to happen in the end?’…
No, no I don’t.” Mildred.
Three other participants were more ambivalent:
“I haven’t asked, and nobody’s said anything, is, how
will the end arrive, you know. Will it be painful? Will
it be a nuisance … or will it just, you know, fade
away? I don’t know…”
“I’m wondering, you know, what, you know, will I be
so doddery I won’t be able to move or make a cup
a tea or something… that’s the only thing that
worries me… I’m not sure that I want to know. I
wonder sometimes whether I should, but I think,
on balance, I’d rather not know what the future
holds.” Jack.
In contrast, Dorothy reported that she encouraged
open and honest discussion of death and dying by being
frank and direct herself:
“I think it helps if you’re straight with them, then
they’re straight with you… Makes it easier all round…
they know that I want to hear what’s what even if I
am [age 80-84]. And if that’s how I am, then it is eas-
ier isn’t it, for them to tell me what’s going on, no fus-
sing. And we’ve talked about dying… what might
happen and when.” Dorothy.
Dialysis decision-making
Agency and preferences
Of 20 participants, 16 reported that the decision not to
have dialysis was their own:
Interviewer: “Who made the decision?”
Betty: “Ohh… I did, I did. Yes, I was quite clear. Dr
[nephrologist] said I could have dialysis if I wanted it,
but I couldn’t see the point.”
Several reported that their decision was influenced or
reinforced by clinicians’ recommendations, and that this
was reassuring, e.g.
“Some of the doctors that I talk to… say, well if it had
been them they’d have probably made the same
decision, so that reinforces the, the decision I made
was right, and I made it on my own.” Jack.
Dorothy said her clinicians had wanted to give her dia-
lysis and had been ‘surprised’ by her decision. Grace re-
ported that she had encountered resistance from
clinicians:
Interviewer: “So did you make that decision or did the
doctors?”
Grace: “I say no. [Name of daughter] she say no.
Doctors say yes [laughs].”
Interviewer: “So you made it clear to them what you
wanted?”
Grace: “Yeah, yeah. Doctors say to me I be dead by
Christmas without it. Am I dead? [Laughs]. No, no.
no. They don’t know [laughs].”
Four patients reported the treatment decision was
their doctor’s rather than their own. Two of these (Don-
ald and Mildred) could not have dialysis due to existing
comorbidities, and one (Joseph) because of problems
with inserting a fistula. The two patients with comorbid-
ities agreed with the treatment decision and had not
wanted dialysis:
Donald: “No, I didn’t want it [laughs]. Didn’t
want the dialysis. I was better off out of it and I,
I quite agreed with what [name of renal doctor]
was saying... he was the one that says it wouldn’t
be a good thing for me, and I thought well if they
can do something without dialysis, I mean it’s
not broken, don’t interfere, sort of thing,
you know…”.
Interviewer: “And who made the decision would
you say?”
Donald: “Oh, the doctor did, [name of renal doctor]
did alright, he made it all clear, but I agreed with
him… I’d say if I didn’t [laughs].”
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One of the patients with comorbidities said she pre-
ferred that the doctor had made the decision for her, as
it meant the responsibility was not solely her own:
“If I’d had to… then it would be me, wouldn’t it? I
mean it would be me deciding and me feeling
responsible for things, like if it was right or not, and I
don’t know do I? Really I don’t. It’s much better if the
doctor says it, then it’s not down to me like, and I
don’t worry.” Mildred.
Several patients talked about family members’ positive
involvement in the decision, e.g. attending appointments
to ask questions, helping to make the decision, support-
ing the decision made, and taking responsibility for
enacting the patient’s wishes:
“I made it on my own, I came back and told the
boys [his sons] what was happening and, and they
just said, ‘Well it’s your life and your decision, we’ll
back you whatever you do,’ you know, and that
was it.” Harold.
One patient reported that his decision not to have dia-
lysis had met with resistance within his family:
“My wife wanted me to have it, she said, ‘You’ve got to
have it, you just can’t not have it.’ But I told her, it’s
up to me, and I want to live ‘til I die, not stop in a
taxi or sat in the waiting lounge half my life.” Michael.
Reasons for treatment decision
The most commonly cited reason for choosing not to
have dialysis was its effect on quality of life:
Interviewer: “And what was it about dialysis that
really didn’t, you didn’t feel was right for you?”
Charles: “It was a prison sentence, this terrible joining
of a club that you knew had only one door… I wasn’t
surprised at all that they had to work like hell to keep
your spirits up.”
Patients recognised the commitment and impact of
travelling to and from hospital:
“It was the travelling to and from London three times
a week for the dialysis and then it was for four or five
hours, whatever it took.” Colin.
Seven patients described how they drew on knowledge
of other people who had dialysis in judging what its im-
pact could be and deciding not to have it:
“She [friend] died anyway. She died although she had
dialysis, anyway. So what’s the point of that then? See
what I mean… She used to have to be in at a certain
time because she had it at home or something… And
she could never go anywhere because she had to be
back at certain time, yeah. I just couldn’t be bothered
with that [laughing].” Lilian.
The complex logistics of home dialysis were also discussed:
“She showed me the bottle of stuff and I thought…
where am I going to put all that?... I’ll have all that
all in my bungalow? That’s the sort of thing that I
would think of.” Mildred.
Elderly patients raised the idea of a natural lifespan
coming to an end, wishing to avoid medical intervention
and not use resources:
“I’d have to go into hospital and have an operation,
general anaesthetic to have this thing put into you, in
your arm, or whatever it is and then I didn’t want
that either. Not at my age… it is better to go with all
your dignity, doing things your way, not with tubes
and machines and other people dictating… it makes it
all on their terms, not my terms.” Florence.
Some patients reflected that if their spouse were still
alive they might have decided differently.
Feelings about the decision
Four participants reported feeling low/depressed around
the time the treatment decision was made. One had
chosen to have conservative care himself, but then had
doubts before resolving these in further discussion; two
were medically advised conservative management (given
co-morbidities); and the fourth (Joseph) had no option
because of dialysis access problems. For Joseph, this de-
cision was not communicated well, and he described his
reactions to this, especially to being given a prognosis of
only two months, but also how his feelings of depression
subsequently lessened:
“Mentally, I was very depressed when they told me I
couldn’t have the fistula… that was ten months ago, so
I was very depressed then, but I didn’t agree with it,
certainly it wasn’t right what they said about the two
months to go… but now, I don’t know how far I’m
going to go.” Joseph.
Discussion
This study provides an in-depth description of communica-
tion and information provision among patients with ESKD
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receiving conservative care, and their views of the treat-
ment decision. Participants reported variable quality in
staff-patient communication and gaps in the information
provided. Participants described renal clinicians avoiding,
struggling with or failing to have conversations with them
about diagnosis and disease progression. Consequences of
this lack of communication included patients not being able
to adapt their diet/health behaviour earlier in their illness,
not knowing what symptoms or problems were attributable
to their renal disease, and worrying about what would hap-
pen in future. This lack of knowledge compounded the
challenges of living with the uncertainty of CKD5 [30].
Previous studies have reported poor communication
and avoidance of discussions of diagnosis and prognosis
by renal clinicians [31, 32], associated with lack of confi-
dence and ability in breaking bad news and discussing
end of life concerns [33, 34]. Prognostic uncertainty
threatens healthcare providers’ self-perceptions as com-
petent professionals, acting as a barrier to discussions
with patients [35]. Other barriers include a focus on
curative and technological aspects of patient care that
may overlook psychosocial needs [36], feeling unpre-
pared for discussions and uncertain of the best way to
have them [37, 38], and a misperception that these con-
versations cause harm [39]. In fact, evidence suggests
that patient experiences are better when uncertainty is
shared and explained [40, 41]. In our study, participants
contrasted the avoidance behaviour they encountered
with the collaborative and straight-forward approach of
palliative care providers and other renal clinicians.
Participants’ information needs were nuanced and
changed over time. In general, participants wanted infor-
mation about their treatment options and renal disease,
but there were exceptions and caveats. The preferred
amount of information depended on the topic, and there
was ambivalence about receiving prognostic information
and details about the next phase of illness and death.
Other qualitative studies have also reported variation
and ambivalence in patients’ preferences regarding
receiving information and decision-making [31, 42]. In
contrast, North American surveys report that patients
with renal disease want information about end-of-life
issues, including dialysis withdrawal and prognosis
[43–45], with a Canadian study reporting that 95%
would like their physicians to disclose life-expectancy
information without prompting, even if prognosis is
poor [43]. Our findings suggest that the situation is
more complex and nuanced than survey data imply.
We found that patients who were clinically ineligible
for dialysis sometimes felt relieved that the responsibility
had been taken out of their hands, but not having a
choice could also be associated with feeling depressed
around the time of the decision. For other patients, the
decision to have conservative care was commonly
framed as a decision against dialysis, hence how dialysis
was perceived was central to patients’ decision-making.
Dialysis was perceived to be not a cure but a “make do
thing”, a “nuisance” provided on clinicians’ “terms”. As in
Morton et al’s systematic review [46], our participants
were more concerned with the impact of treatment on
their quality of life than on longevity: they were not pre-
pared to undertake the rigours of dialysis, and perceived
its negative impact to outweigh potential benefit. Partici-
pants’ perceptions of dialysis as disrupting and restrict-
ing life echoed those reported in Llewellyn et al’s study
of older people with CKD5 who had declined dialysis
[32]. They described logistical challenges, for example
the need to travel to/from the hospital, which have pre-
viously been reported as important [31, 46]. Unlike in
Morton’s review, participants had not consulted with
peers to understand palliative care as an option; how-
ever, they did consider others’ experiences on dialysis
when making their decision and judging what dialysis
might be like.
In our study, although most patients reported that the
decision not to have dialysis was their own, clinicians’
recommendations played an important role in influen-
cing and reassuring them. This finding aligns with co-
hort studies demonstrating that clinicians’ views are a
major factor influencing patients’ treatment decision-
making [47, 48]. As also reported by Llewellyn et al.
[32], we found evidence of renal clinicians resisting a pa-
tient’s decision not to dialyse. While family members
often played a supportive role, the treatment decision
could lead to conflict. Our older group of patients also
discussed their wish to respect the natural life span,
avoid medical intervention, and not use up resources,
supporting Australian [49] and UK [32] findings.
This study has strengths and weaknesses. The study
sample represents a maximum variation sample, with re-
gard to age, living situation, levels of co-morbidity and
functional status, which adequately reflects the variabil-
ity within this population. Most participants in the study
were of white ethnicity, reflecting the UK population
and the catchment population for the three renal units.
However, patients from minority ethnic groups might
have different experiences, views and preferences regard-
ing discussions of treatment and end of life care [50].
Further interviews with individuals from Black, Asian
and minority ethnic communities would have increased
the transferability of findings. The sample of 20 enabled
in-depth analysis while achieving sufficient information
power (including data saturation) to meet the study aims
[51]. However, this study did not include clinicians or in-
formal caregivers, who play an important role in sup-
porting older patients and their decision-making [46],
particularly when patients experience cognitive impair-
ment. The data were collected in 2007, when the
Selman et al. BMC Nephrology           (2019) 20:38 Page 9 of 12
recruiting sites were actively interested in or were devel-
oping conservative management services. At other renal
services at that time the culture of care might have been
less supportive of conservative care; hence our findings
might underestimate gaps in information and the extent
to which staff avoided/struggled with discussing
end-of-life issues. Since 2007 conservative care has be-
come a more accepted component of renal care. While it
is possible that this has led to improvements in communi-
cation, there is recent evidence of problematic practice;
for example, the 2017 UK Renal Registry patient experi-
ence survey found that communication and clinicians’
decision-making support were highly variable across renal
units, with decision-making support rated lowest of all 13
service areas [15]. This problematic practice, together with
the ongoing lack of research exploring the views and expe-
riences of patients receiving conservative care, means our
findings are still highly relevant.
Our findings have implications for clinical practice,
education and research. They support the hypothesis
that renal clinicians’ perceptions and recommendations
regarding treatment influence patients’ decision-making.
To further inform education, research is needed to bet-
ter understand how the way healthcare providers com-
municate with patients and caregivers, and the
information provided, influences the process and experi-
ence of decision-making. This includes research into
how the use of information leaflets, decision aids and
other shared decision-making tools (https://www.en-
gland.nhs.uk/rightcare/shared-decision-making/) influ-
ence patients’ experiences of communication and
decision-making and its outcomes. This evidence is cru-
cial to support renal clinicians in the complex work of
tailoring how they communicate with patients, provide
information, and support treatment decision-making.
Collaboration between palliative care specialists and
renal clinicians is essential in providing high-quality
ESKD care, and palliative care clinicians play an import-
ant role in supporting renal clinicians’ communication
with patients. However, conversations about the uncer-
tainties of renal disease and treatment options need to
occur upstream in the disease trajectory, hence renal
clinicians must be well-equipped to manage them.
Eliciting patients’ information-, communication- and de-
cision-making preferences in a sensitive and ongoing
manner, and tailoring care accordingly, is critical to
patient-centred care. Assessment tools can assist with
this process [52] (see https://pos-pal.org). However, renal
clinicians struggle with the complexity of the communi-
cation required of them [11] and want training on how
to discuss conservative management [53]. Patients also
want improvements in how renal clinicians communi-
cate and support their decision-making [15], as reflected
in our findings. We recommend that renal clinical
training and education includes how to share and ex-
plain the uncertainty of kidney disease, consequences of
not discussing diagnosis/prognosis, nuances in informa-
tion preferences and how to elicit these, tailoring infor-
mation to be patient-centred, how clinicians’ framing of
information influences patients’ decision-making, and
responding to patients’ stated treatment decisions. Edu-
cation which is based on direct observational evidence
[54] and incorporates discussion of real patient-clinician
consultations [55] may be most effective at changing
clinician behaviour [55].
Conclusions
Older patients report variable quality in communication
with clinicians and gaps in the information received. Un-
certainty about the disease trajectory and patients’ am-
bivalence regarding information makes communication
particularly challenging for clinicians. Findings suggest
that: (1) eliciting patient information preferences, tailor-
ing information accordingly and conveying it clearly and
sensitively is critical; and (2) nephrology training should
include how to elicit patient decision-making prefer-
ences and values and make a CKD treatment recom-
mendation that aligns with them. Our findings can
inform support and training for renal clinicians to en-
sure decision-making support for older patients is
patient-centred.
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